NPY receptors in human cancer: A review of current knowledge

This publication has 29 references indexed in Scilit:

• The Antitumoral Effects of Somatostatin Analog Therapy in Acromegaly
  Journal of Clinical Endocrinology & Metabolism, 2005
• Differential Effects of Neuropeptide Y on the Growth and Vascularization of Neural Crest–Derived Tumors
  Cancer Research, 2005
• High Expression of Neuropeptide Y Receptors in Tumors of the Human Adrenal Gland and Extra-Adrenal Paraganglia
  Clinical Cancer Research, 2004
• Introduction to the reviews on neuropeptide Y
  Neuropeptides, 2004
• Neuropeptide Y receptor expression in human primary ovarian neoplasms
  Laboratory Investigation, 2004
• The clinical role of somatostatin analogues as antineoplastic agents: much ado about nothing?
  Annals of Oncology, 2002
• NPY Regulates Catecholamine Secretion from Human Adrenal Chromaffin Cells
  Journal of Clinical Endocrinology & Metabolism, 2001
• Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours
  British Journal of Cancer, 2000
• Production, characterization, and expression of neuropeptide Y by human pheochromocytoma.
  Journal of Clinical Investigation, 1995
• Neuropeptide Y (NPY)- and vasoactive intestinal peptide (VIP)-induced aldosterone secretion by rat capsule/glomerular zone could be mediated by catecholamines via β1 adrenergic receptors
  Neuroscience Letters, 1994